Cargando…
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255125/ https://www.ncbi.nlm.nih.gov/pubmed/32450054 http://dx.doi.org/10.1016/S1473-3099(20)30430-8 |
_version_ | 1783539669889187840 |
---|---|
author | Tilangi, Praveen Desai, Devashish Khan, Adil Soneja, Manish |
author_facet | Tilangi, Praveen Desai, Devashish Khan, Adil Soneja, Manish |
author_sort | Tilangi, Praveen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7255125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72551252020-05-28 Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach Tilangi, Praveen Desai, Devashish Khan, Adil Soneja, Manish Lancet Infect Dis Correspondence Elsevier Ltd. 2020-10 2020-05-22 /pmc/articles/PMC7255125/ /pubmed/32450054 http://dx.doi.org/10.1016/S1473-3099(20)30430-8 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Tilangi, Praveen Desai, Devashish Khan, Adil Soneja, Manish Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title | Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title_full | Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title_fullStr | Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title_full_unstemmed | Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title_short | Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach |
title_sort | hydroxychloroquine prophylaxis for high-risk covid-19 contacts in india: a prudent approach |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255125/ https://www.ncbi.nlm.nih.gov/pubmed/32450054 http://dx.doi.org/10.1016/S1473-3099(20)30430-8 |
work_keys_str_mv | AT tilangipraveen hydroxychloroquineprophylaxisforhighriskcovid19contactsinindiaaprudentapproach AT desaidevashish hydroxychloroquineprophylaxisforhighriskcovid19contactsinindiaaprudentapproach AT khanadil hydroxychloroquineprophylaxisforhighriskcovid19contactsinindiaaprudentapproach AT sonejamanish hydroxychloroquineprophylaxisforhighriskcovid19contactsinindiaaprudentapproach |